Cargando…
Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer
| Autores principales: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845345/ https://www.ncbi.nlm.nih.gov/pubmed/36650166 http://dx.doi.org/10.1038/s41467-023-35969-4 |
| _version_ | 1784870885937643520 |
|---|---|
| author | Coombes, R. C. Badman, P. D. Lozano-Kuehne, J. P. Liu, X. Macpherson, I. R. Zubairi, I. Baird, R. D. Rosenfeld, N. Garcia-Corbacho, J. Cresti, N. Plummer, R. Armstrong, A. Allerton, R. Landers, D. Nicholas, H. McLellan, L. Lim, A. Mouliere, F. Pardo, O. E. Ferguson, V. Seckl, M. J. |
| author_facet | Coombes, R. C. Badman, P. D. Lozano-Kuehne, J. P. Liu, X. Macpherson, I. R. Zubairi, I. Baird, R. D. Rosenfeld, N. Garcia-Corbacho, J. Cresti, N. Plummer, R. Armstrong, A. Allerton, R. Landers, D. Nicholas, H. McLellan, L. Lim, A. Mouliere, F. Pardo, O. E. Ferguson, V. Seckl, M. J. |
| author_sort | Coombes, R. C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9845345 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98453452023-01-19 Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer Coombes, R. C. Badman, P. D. Lozano-Kuehne, J. P. Liu, X. Macpherson, I. R. Zubairi, I. Baird, R. D. Rosenfeld, N. Garcia-Corbacho, J. Cresti, N. Plummer, R. Armstrong, A. Allerton, R. Landers, D. Nicholas, H. McLellan, L. Lim, A. Mouliere, F. Pardo, O. E. Ferguson, V. Seckl, M. J. Nat Commun Author Correction Nature Publishing Group UK 2023-01-17 /pmc/articles/PMC9845345/ /pubmed/36650166 http://dx.doi.org/10.1038/s41467-023-35969-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Author Correction Coombes, R. C. Badman, P. D. Lozano-Kuehne, J. P. Liu, X. Macpherson, I. R. Zubairi, I. Baird, R. D. Rosenfeld, N. Garcia-Corbacho, J. Cresti, N. Plummer, R. Armstrong, A. Allerton, R. Landers, D. Nicholas, H. McLellan, L. Lim, A. Mouliere, F. Pardo, O. E. Ferguson, V. Seckl, M. J. Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer |
| title | Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer |
| title_full | Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer |
| title_fullStr | Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer |
| title_full_unstemmed | Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer |
| title_short | Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer |
| title_sort | author correction: results of the phase iia radical trial of the fgfr inhibitor azd4547 in endocrine resistant breast cancer |
| topic | Author Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845345/ https://www.ncbi.nlm.nih.gov/pubmed/36650166 http://dx.doi.org/10.1038/s41467-023-35969-4 |
| work_keys_str_mv | AT coombesrc authorcorrectionresultsofthephaseiiaradicaltrialofthefgfrinhibitorazd4547inendocrineresistantbreastcancer AT badmanpd authorcorrectionresultsofthephaseiiaradicaltrialofthefgfrinhibitorazd4547inendocrineresistantbreastcancer AT lozanokuehnejp authorcorrectionresultsofthephaseiiaradicaltrialofthefgfrinhibitorazd4547inendocrineresistantbreastcancer AT liux authorcorrectionresultsofthephaseiiaradicaltrialofthefgfrinhibitorazd4547inendocrineresistantbreastcancer AT macphersonir authorcorrectionresultsofthephaseiiaradicaltrialofthefgfrinhibitorazd4547inendocrineresistantbreastcancer AT zubairii authorcorrectionresultsofthephaseiiaradicaltrialofthefgfrinhibitorazd4547inendocrineresistantbreastcancer AT bairdrd authorcorrectionresultsofthephaseiiaradicaltrialofthefgfrinhibitorazd4547inendocrineresistantbreastcancer AT rosenfeldn authorcorrectionresultsofthephaseiiaradicaltrialofthefgfrinhibitorazd4547inendocrineresistantbreastcancer AT garciacorbachoj authorcorrectionresultsofthephaseiiaradicaltrialofthefgfrinhibitorazd4547inendocrineresistantbreastcancer AT crestin authorcorrectionresultsofthephaseiiaradicaltrialofthefgfrinhibitorazd4547inendocrineresistantbreastcancer AT plummerr authorcorrectionresultsofthephaseiiaradicaltrialofthefgfrinhibitorazd4547inendocrineresistantbreastcancer AT armstronga authorcorrectionresultsofthephaseiiaradicaltrialofthefgfrinhibitorazd4547inendocrineresistantbreastcancer AT allertonr authorcorrectionresultsofthephaseiiaradicaltrialofthefgfrinhibitorazd4547inendocrineresistantbreastcancer AT landersd authorcorrectionresultsofthephaseiiaradicaltrialofthefgfrinhibitorazd4547inendocrineresistantbreastcancer AT nicholash authorcorrectionresultsofthephaseiiaradicaltrialofthefgfrinhibitorazd4547inendocrineresistantbreastcancer AT mclellanl authorcorrectionresultsofthephaseiiaradicaltrialofthefgfrinhibitorazd4547inendocrineresistantbreastcancer AT lima authorcorrectionresultsofthephaseiiaradicaltrialofthefgfrinhibitorazd4547inendocrineresistantbreastcancer AT moulieref authorcorrectionresultsofthephaseiiaradicaltrialofthefgfrinhibitorazd4547inendocrineresistantbreastcancer AT pardooe authorcorrectionresultsofthephaseiiaradicaltrialofthefgfrinhibitorazd4547inendocrineresistantbreastcancer AT fergusonv authorcorrectionresultsofthephaseiiaradicaltrialofthefgfrinhibitorazd4547inendocrineresistantbreastcancer AT secklmj authorcorrectionresultsofthephaseiiaradicaltrialofthefgfrinhibitorazd4547inendocrineresistantbreastcancer |